Characterization of P2 receptors for purine and pyrimidine nucleotides in human placental cotyledons

British Journal of Pharmacology

Volumn 121, Issue 6, 1997, Pages 1121-1126

  Ralevic, Vera ^a   Burrell, Stephen ^a   Kingdom, John ^a   Burnstock, Geoffrey ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Endothelium; P2 receptors; Perfusion; Placenta; PPADS; Pyrimidine receptors

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CYTIDINE TRIPHOSPHATE; GUANOSINE TRIPHOSPHATE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN F2 ALPHA; PURINE NUCLEOTIDE; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIMIDINE NUCLEOTIDE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ARTICLE; BLOOD VESSEL TONE; BOLUS INJECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DRUG POTENCY; FEMALE; HUMAN; HUMAN TISSUE; PERFUSION; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; SMOOTH MUSCLE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ADULT; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HUMANS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PLACENTA; PREGNANCY; PURINE NUCLEOTIDES; PYRIDOXAL PHOSPHATE; PYRIMIDINE NUCLEOTIDES; RECEPTORS, PURINERGIC P2; VASOCONSTRICTOR AGENTS;

EID: 0030738489     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701262     Document Type: Article

References (35)

1. ABBRACCHIO, M.P. & BURNSTOCK, G. (1994). Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol. Ther., 64, 445-475.
2. ALFIREVIC, Z. & NEILSON, J.P. (1995). Doppler ultrasonography in high-risk pregnancies: systematic review with meta-analysis. Am. J. Obstet. Gynecol., 172, 1379-1387.
3. BUELL, G., LEWIS, C., COLLO, G., NORTH, R.A. & SURPRENANT, A. (1996). An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J., 15, 55-62.
4. 2-purinoceptor? Gen. Pharmacol., 16, 433-440.
5. 2 nucleotide receptor. J. Biol. Chem., 270, 26152-26158.
6. 6 receptors, and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci., 16, 2495-2507.
7. COMMUNI, D., PIROTTON, S., PARMENTIER, M. & BOEYNAEMS, J.-M. (1996a). Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem., 270, 30849-30852.
8. 6 receptor. Biochem. Biophys. Res. Commun., 222, 303-308.
9. CRACK, B.E., BEUKERS, M.W., MCKECHNIE, K.C.W., IJZERMAN, A.P. & LEFF, P. (1994). Pharmacological analysis of ecto-ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X-purinoceptor ligands. Br. J. Pharmacol., 113, 1432-1438.
10. 2+ in single rat hepatocytes mimicked by 2-methylthioATP. Br. J. Pharmacol., 116, 1979-1984.
11. DOBRONYI, I., HUNG, K.-S., SATCHELL, D.G. & MAGUIRE, M.H. (1997). Evidence for a novel P2X purinoceptor in human placental chorionic surface arteries. Eur. J. Pharmacol., 320, 61-64.
12. DUBYAK, G.R. & EL-MOATASSIM, C. (1993). Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol., 265, C577-C606.
13. EVANS, R.J. & SURPRENANT, A. (1996). P2X receptors in autonomic and sensory neurons. Seminars Neurosci., 8, 217-223.
14. FEOLDE, E., VIGNE, P., BREITTMAYER, J.P. & FRELIN, C. (1995). ATP, a partial agonist of atypical P2Y purinoceptors in rat brain microvascular endothelial cells. Br. J. Pharmacol., 115, 1199-1203.
15. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, K.T., JACOBSON, K.A., LEFF, P. & WILLIAMS, M. (1994). Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
16. 2+ mobilization in brain capillary endothelial cells. J. Biol. Chem., 268, 8787-8792.
17. 4 receptor reveals pharmacological differences to the rat homologue. Mol. Phramacol., 51, 109-118.
18. 1 purinoceptor. Direct submission of Z49205 to Genbank.
19. NORTH, R.A. (1996). P2X purinoceptor plethora. Seminars Neurosci., 8, 187-194.
20. OLSSON, R.A. & PEARSON, J.D. (1990). Cardiovascular purinoceptors. Physiol. Rev., 70, 761-845.
21. PETIT, A. & BÉLISLE, S. (1995). Stimulation of intracellular calcium concentration by adenosine triphosphate and uridine 5′-triphosphate in human term placental cells: evidence for purinergic receptors. J. Clin. Endocrinol. Metab., 80, 1809-1815.
22. RALEVIC, V. & BURNSTOCK, G. (1988). Actions mediated by P2-purinoceptor subtypes in the isolated perfused mesenteric bed of the rat. Br. J. Pharmacol., 95, 49-56.
23. RALEVIC, V. & BURNSTOCK, G. (1991). Effects of purines and pyrimidines on the rat mesenteric arterial bed. Circ. Res., 69, 1583-1590.
24. RALEVIC, V. & BURNSTOCK, G. (1996). Discrimination by PPADS between endothelial P2Y- and P2U-purinoceptors in the rat isolated mesenteric arterial bed. Br. J. Pharmacol., 118, 428-434.
25. RALEVIC, V., BURRELL, S., KINGDOM, J. & BURNSTOCK, G. (1996). Role of purine and pyrimidine nucleotides in the control of vascular tone in the human placenta. Drug Dev. Res., 37, 135.
26. G-Nitro-L-arginine methyl ester attenuates vasodilator responses to acetylcholine but enhances those to sodium nitroprusside. J. Pharm. Pharmacol., 43, 871-874.
27. READ, M.A., BOURA, A.L.A. & WALTERS, W.A.W. (1993). Vascular actions of purines in the foetal circulation of the human placenta. Br. J. Pharmacol., 110, 454-460.
28. 2+] in rat osteoblastic cells by interaction with two receptor subtypes. Am. J. Physiol., 263, C1040-C1048.
29. SAIAG, B., MILON, D., ALLAIN, H., RAULT, B. & DRIESSCHE, V.D. (1990). Constriction of the smooth muscle of rat tail and femoral arteries and dog saphenous vein is induced by uridine triphosphate via 'pyrimidinoceptors', and by adenosine triphosphate via P2X purinoceptors. Blood Vessels, 27, 352-364.
30. SAIAG, B., MILON, D., SHACOORI, V., ALLAIN, H., RAULT, B. & VAN DEN DRIESSCHE, J. (1992). Newly evidenced pyrimidinoceptors and the P2X purinoceptors are present on the vascular smooth muscle and respectively mediate the UTP- and ATP-induced contractions of the dog maxilliary internal vein. Res. Commun. Chem. Pathol. Pharmacol., 76, 89-94.
31. SHIRASAKI, Y. & SU, C. (1985). Endothelium removal augments vasodilation by sodium nitroprusside and sodium nitrite. Eur. J. Pharmacol., 114, 93-96.
32. VON KÜGELGEN, I., HÄUSSINGER, D. & STARKE, K. (1987). Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn-Schmiedeberg's Arch. Pharmacol., 336, 556-560.
33. WEBB, T.E., FEOLDE, E., VIGNE, P., NEARY, J.T., RUNBERG, A., FRELIN, C. & BARNARD, E.A. (1996). The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase. Br. J. Pharmacol., 119, 1385-1392.
34. WINDSCHEIF, U., RALEVIC, V., BÄUMERT, H.G., MUTSCHLER, E., LAMBRECHT, G. & BURNSTOCK, G. (1994). Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2X-purinoceptors. Br. J. Pharmacol., 113, 1015-1021.
35. ZIGANSHIN, A.U., HOYLE, C.H.V., LAMBRECHT, G., MUTSCHLER, E., BÄUMERT, H.G. & BURNSTOCK, G. (1994). Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels. Br. J. Pharmacol., 111, 923-929.